Archived dengue serum samples produced false-positive results in SARS-CoV-2 lateral flow-based rapid antibody tests

References

1. Coronavirus disease (COVID-19) Situation Report-209 Situation in numbers (by WHO Region). https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200816-covid-19-sitrep-209.pdf?sfvrsn=5dde1ca2_2 accessed 1 Mar 2021
2. Yan G, Lee CK, Lam LTM, Yan B, Chua YX et al. Covert COVID-19 and false-positive dengue serology in Singapore. Lancet Infect Dis 2020; 20:536 [View Article]
   [Google Scholar]
3. Lustig Y, Keler S, Kolodny R, Ben-Tal N, Atias-Varon D et al. Potential antigenic cross-reactivity between sars-cov-2 and dengue viruses. Clin Infect Dis 2020; 2:1–6[PubMed]
   [Google Scholar]
4. Wu D, Lu J, Liu Q, Ma X, He W. To alert co-infection of sars-cov-2 and dengue virus in developing countries in the dengue-endemic area. Infect Control Hosp Epidemiol 2020; 1:
   [Google Scholar]
5. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW et al. The global distribution and burden of dengue. Nature 2013; 496:504–507 [View Article][PubMed]
   [Google Scholar]
6. Sukla S, Ghosh A, Saha R, De A, Adhya S et al. In-depth molecular analysis of a small cohort of human and Aedes mosquito (adults and larvae) samples from Kolkata revealed absence of zika but high prevalence of dengue virus. J Med Microbiol 2018; 67:1109–1119 [View Article][PubMed]
   [Google Scholar]
7. National Vector Borne Disease Control Programme; Ministry of Health and Family Welfare, Government of India. https://nvbdcp.gov.in/index4.php?lang=1&level=0&linkid=431&lid=3715 accessed 25 Feb 2021
8. Nath H, Mallick A, Roy S, Sukla S, Biswas S. Computational modelling supports that dengue virus envelope antibodies can bind to SARS-CoV-2 receptor binding sites: Is pre-exposure to dengue virus protective against COVID-19 severity?. Comput Struct Biotechnol J 2021; 19:459–466 [View Article][PubMed]
   [Google Scholar]
9. Nath H, Mallick A, Roy S, Sukla S, De A et al. Dengue antibodies can cross-react with sars-cov-2 and vice versa-aantibody detection kits can give false-positive results for both viruses in regions where both COVID-19 and Dengue co-exist. medRxiv 2020 [View Article]
   [Google Scholar]
10. Hicks J, Klumpp-Thomas C, Kalish H, Shunmugavel A, Mehalko J et al. Serologic cross-reactivity of SARS-CoV-2 with endemic and seasonal Betacoronaviruses. medRxiv 2020 [View Article][PubMed]
    [Google Scholar]
11. Lv H, Wu NC, Tsang O-Y, Yuan M, Perera R et al. Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections. Cell Rep 2020; 31:107725 [View Article][PubMed]
    [Google Scholar]
12. Shrock E, Fujimura E, Kula T, Timms RT, Lee I-. H et al. Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity. Science 2020; 370: [View Article][PubMed]
    [Google Scholar]
13. Su S, Wong G, Shi W, Liu J, Lai ACK et al. Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses. Trends Microbiol 2016; 24:490–502 [View Article][PubMed]
    [Google Scholar]
14. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. https://www.who.int/publications/m/item/summary-of-probable-sars-cases-with-onset-of-illness-from-1-november-2002-to-31-july-2003 accessed 24 Feb 2021
15. Spinicci M, Bartoloni A, Mantella A, Zammarchi L, Rossolini GM et al. Low risk of serological cross-reactivity between dengue and COVID-19. Mem Inst Oswaldo Cruz 2020; 115:e200225 [View Article][PubMed]
    [Google Scholar]
16. Biswas S, Sukla S. COVID-19 virus infection and transmission are observably less in highly dengue-endemic countries: Is pre-exposure to dengue virus protective against COVID-19 severity and mortality? Will the reverse scenario be true?. Clin Exp Investig 2020; 1:1–5 [View Article]
    [Google Scholar]